Intra-arterial Methylprednisolone After Endovascular Thrombectomy
A phase 2 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 210 participants.
Also called NCT07516522
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 210 participants
- Sponsor
- Registry
-
NCT07516522
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Recruiting
Technical summary
Registry record NCT07516522. Randomized; quadruple masking; primary purpose treatment. Start 2026-03-31 (actual); primary completion 2027-12-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Intra-arterial Methylprednisolone After Endovascular Thrombectomy
- Acronym
- IMPACT-LVO
- Condition
- Ischemia Stroke
- Condition
- Thrombectomy
- Condition
- Large Vessel Occlusion
- Intervention (Drug)
- The methylprednisolone sodium succinate group
- Intervention (Drug)
- The placebo group
- Lead sponsor
- Tang-Du Hospital
Record details
- Record id
cardio:ct-nct07516522- Content hash
9386c2956ad061edf26abb243e6e00f440f940a151081558d4d730cf09484aa5